15 August 2026

Aurobindo Pharma facility warning

This event serves as context for understanding the challenges of quality control and regulatory compliance in India's pharmaceutical sector, which is a significant component of the country's industrial policy and export economy.

Questions

1. The pharmaceutical sector in India is a critical component of the global supply chain. Discuss the implications of regulatory scrutiny by international bodies like the U.S. FDA on the quality standards and global competitiveness of Indian pharmaceutical manufacturing units. 150 words
   Attempt this — 150 words in 8 min

   0 / 150 words 8:00 Reset

Prelims

1. Which of the following best describes the 'Official Action Indicated' (OAI) status issued by the U.S. FDA to a manufacturing facility?

   1. A A certification that the facility meets all international Good Manufacturing Practices.
   2. B A classification indicating that regulatory or administrative actions are necessary based on inspection findings.
   3. C A voluntary closure notice issued by the company to upgrade its infrastructure.
   4. D A final clearance granted after all previous inspection observations have been resolved.